Catalyst News and Research

RSS

Scientist finds man-made chemical enzyme to neutralize toxin

For the first time ever, a completely man-made chemical enzyme has been successfully used to neutralise a toxin found naturally in fruits and vegetables. While studying for her PhD in chemistry at the University of Copenhagen Dr. Jeannette Bjerre showed how a novel so called chemzyme was able to decompose glycoside esculin, a toxin found in horse-chestnuts.

27 Aug 2010

Nightingale first-quarter revenue increases to $4.4 million

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the first quarter ended June 30, 2010. All results are reported in Canadian dollars unless otherwise stated.

26 Aug 2010

Administrative Law Judge recommends grant of Certificate of Need for Trinity Medical Center's relocation

Trinity Medical Center achieved a major victory today in its effort to gain state regulatory approval for a new, state-of-the-art hospital facility on Highway 280. Administrative Law Judge (ALJ) James Hampton has issued his recommendation in favor of granting the required Certificate of Need (CON) for Trinity's relocation from its 44-year old campus on Montclair Road to the new hospital facility. The decision follows months of deliberation and a comprehensive review of the facts during what was the longest ALJ hearing on a healthcare matter in Alabama history.

25 Aug 2010

CIMIT, Induct announce strategic alliance to implement Web-based innovation management system

The Center for Integration of Medicine and Innovative Technology and Induct Software, "The Open Innovation Company," today announced a long-term strategic alliance under which they will work together to implement a Web-based innovation management system based upon the successful CIMIT Model.

25 Aug 2010

AdvanSource Biomaterials enters multi-year agreement to supply hydrophilic polymer resins

AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced that the Company has entered into a multi-year supply agreement with a leading multi-national medical device company. This supply agreement is the result of the Company's successful performance on a development agreement, which was entered into with this customer in June 2009.

25 Aug 2010

Alnylam Pharmaceuticals to present results on RNAi therapeutics at ACS National Meeting

Alnylam Pharmaceuticals, Inc.,a leading RNAi therapeutics company, announced today that it will make a total of 16 oral presentations at the American Chemical Society (ACS) Fall 2010 240th National Meeting & Exposition being held in Boston, Mass. from August 22-26, 2010.

24 Aug 2010

NCF announces formal disease model for Chronic Fatigue Syndrome

The National CFIDS Foundation Inc., of Needham Mass, has announced its formal disease model for Chronic Fatigue Syndrome (CFS) also known as Chronic Fatigue Immune Dysfunction Syndrome (CFIDS) as well as Myalgic Encephalomyelitis (ME). According to the NCF, a subgroup of patients with CFS fit a unique disease profile based on a model for a radioactive toxin.

21 Aug 2010

MINDBODY receives fund from two venture capital firms

MINDBODY, Inc., the industry leader in cloud-based, business management software for health and wellness organizations worldwide, has received a major investment from two of the country's most respected venture capital firms, Bessemer Venture Partners and Catalyst Investors.

21 Aug 2010

Catalyst Health Solutions named on 2010 Fortune 100 Fastest-Growing Companies List

Catalyst Health Solutions, Inc., announced today that it was named to the 2010 Fortune 100 Fastest-Growing Companies List. Catalyst has achieved this recognition for three consecutive years and four times in six years. The Company was also named on Fortune's Fastest-Growing All-Stars List.

21 Aug 2010

The Center for Pediatric Dentistry opens in Seattle on September 1, 2010

At today's ribbon cutting ceremony, The Center for Pediatric Dentistry, created to address the growing epidemic of childhood dental disease, announced the grand opening of its facility on September 1, 2010. The Seattle-based institute is the first of its kind in the country, providing pediatric dental care, education for dentists and medical professionals, research, and policy under one roof.

20 Aug 2010

AACR opens nominations for awards recognizing excellence in cancer research

The American Association for Cancer Research is currently accepting nominations for awards recognizing excellence in cancer research, to be presented at the 102nd AACR Annual Meeting 2011, held in Orlando, Fla., from April 2 to 6.

18 Aug 2010

Emerging Healthcare Solutions announces new website of Stand-By Systems

Emerging Healthcare Solutions, Inc. disclosed today that Stand-By Systems (SBS) has established an Internet presence by launching a website that describes their company and its ground-breaking products. EHSI is currently moving to finalize a Definitive Agreement with SBS and has already executed a term sheet for the deal, which was announced on August 2nd.

17 Aug 2010

Pernix Therapeutics reports decrease in net sales for 2010 second quarter

Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company primarily focused on the pediatric market, today announced results for the quarter and six months ended June 30, 2010.

17 Aug 2010

ISCT partners with leading companies in cell therapy regenerative medicine market to drive clinical development

Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment within the industry and drive late stage clinical development.

16 Aug 2010

Catalyst second-quarter net loss decreases to $1,328,541

Catalyst Pharmaceutical Partners, Inc. today announced its financial results for the second quarter and six months ended June 30, 2010.

13 Aug 2010

Tengion announces clinical, corporate and second-quarter financial updates

Tengion Inc. today provided a corporate and product development update and reported its financial results for the quarter ended June 30, 2010.

12 Aug 2010

Study results provide rationale for use of PI3K inhibitors in therapeutic settings

Research at the Babraham Institute, investigating how white blood cells known as B cells develop, has revealed that genes from the Phosphatidylinositol 3-kinase family of enzymes are critical in enabling the B cells to produce antibodies in the spleen and lymph nodes.

10 Aug 2010

Catalyst announces $1.5 million registered direct offering

Catalyst Pharmaceutical Partners, Inc. today announced that it has entered into definitive agreements to sell 1,351,352 shares of its common stock at a price per share of $1.11 pursuant to a registered direct offering to two large mutual funds, representing gross proceeds of $1.5 million.

7 Aug 2010

Elsevier Properties congratulates Stewart for achieving Lectureship

Elsevier Properties SA is pleased to congratulate Dr. Scott Stewart on his winning the Royal Australian Chemical Institute's (RACI) 2010/11 Athel Beckwith Lectureship, sponsored by Reaxys.

6 Aug 2010

Catalyst Health Solutions second-quarter 2010 net income up 21%

Catalyst Health Solutions, Inc., a pharmacy benefit management company, today announced its financial results for the quarter ended June 30, 2010. The Company reported quarterly net income of $19.5 million, up 21% compared to $16.2 million in the prior year. Earnings per diluted share increased by $0.07 to $0.44 from $0.37. Revenue for the quarter ended June 30, 2010, grew by 24% to $890.1 million from $717.6 million in the prior year.

5 Aug 2010

Catalyst News and Research

Scientist finds man-made chemical enzyme to neutralize toxin

Nightingale first-quarter revenue increases to $4.4 million

Administrative Law Judge recommends grant of Certificate of Need for Trinity Medical Center's relocation

CIMIT, Induct announce strategic alliance to implement Web-based innovation management system

AdvanSource Biomaterials enters multi-year agreement to supply hydrophilic polymer resins

Alnylam Pharmaceuticals to present results on RNAi therapeutics at ACS National Meeting

NCF announces formal disease model for Chronic Fatigue Syndrome

MINDBODY receives fund from two venture capital firms

Catalyst Health Solutions named on 2010 Fortune 100 Fastest-Growing Companies List

The Center for Pediatric Dentistry opens in Seattle on September 1, 2010

AACR opens nominations for awards recognizing excellence in cancer research

Emerging Healthcare Solutions announces new website of Stand-By Systems

Pernix Therapeutics reports decrease in net sales for 2010 second quarter

ISCT partners with leading companies in cell therapy regenerative medicine market to drive clinical development

Catalyst second-quarter net loss decreases to $1,328,541

Tengion announces clinical, corporate and second-quarter financial updates

Study results provide rationale for use of PI3K inhibitors in therapeutic settings

Catalyst announces $1.5 million registered direct offering

Elsevier Properties congratulates Stewart for achieving Lectureship

Catalyst Health Solutions second-quarter 2010 net income up 21%

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News